- Health Rising

The 2025 Berlin International ME/CFS Research Conference is Almost Here!

Help for Sleep in ME/CFS and Fibromyalgia Coming? New Sleep Drug Suvorexant Expected to Hit the Market This Year

by Cort Johnson | Jul 22, 2013 | Sleep

Suvorexant, possibly the first FDA approved drug for insomnia in 30 years, could begin spelling relief for ME/CFS and FM patients later this year.

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

BECOME A RECURRING DONOR

GIVE A ONE-TIME DONATION

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Knocked Out Of The Job Of a Lifetime

Bob Graybosch

Lahaina, United States

Former occupation: Resort General Manager

Total Economic Losses:

$1,261,443

Lives Interrupted Stats

Number of Stories: 44

Years of Work Lost: 337

Average Total Economic Losses:

$880,434

Total Economic Losses:

$28,173,900

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

A BIG thanks to the 550 people whose $57K in donations made Health Rising's winter drive a success :)

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

The 2025 Berlin International ME/CFS Research Conference is Almost Here!

Help for Sleep in ME/CFS and Fibromyalgia Coming? New Sleep Drug Suvorexant Expected to Hit the Market This Year

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest